Search

Search Results

• CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

  Vincenzo De Sanctis

  e2020006

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.006

  4245

  PDF: 1517

  HTML: 447

• DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA

  Sudhansu Sekhar Nishank

  e2015046

  2015-07-02

  https://doi.org/10.4084/mjhid.2015.046

  1538

  PDF: 785

  HTML: 1476

  Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 179

• TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML

  Buket Altinok Gunes, Tulin OZKAN, Aynur Karadag Gurel, Semih Dalkilic, Nevin Belder, Zeynep Ozkeserli, Hilal Ozdag Sevgili, Meral Beksac, Nilgun Sayinalp, Abdullah Munci Yagci, Asuman Sunguroglu

  e2024058

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.058

  1043

  PDF: 1154

  Suppl. Files: 569

  HTML: 88

• GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

  Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau

  e2011019

  2011-05-16

  https://doi.org/10.4084/mjhid.2011.019

  2580

  PDF: 799

  HTML: 5214

• EBV CHRONIC INFECTIONS

  Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti

  e2010022

  2010-08-09

  https://doi.org/10.4084/mjhid.2010.022

  3480

  PDF: 1577

  HTML: 7804

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

  Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava

  e2011056

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.056

  3639

  PDF: 931

  HTML: 4452

• TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

  Agustin Avilès, Maria-Jesus Nambo, Natividad Neri

  e2018006

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.006

  3554

  PDF: 1067

  HTML: 874

• OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE

  Grzegorz Helbig, Grazyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien

  e2015003

  2015-01-01

  https://doi.org/10.4084/mjhid.2015.003

  2221

  PDF: 1046

  HTML: 1982

  Characteristic of study group: 198

• Association of the SOD2 polymorphism (Val6Ala) and SOD activity with vaso-occlusive crisis and acute splenic sequestration in children with sickle cell anemia

  Isabela Cristina Cordeiro Farias, Taciana Furtado Mendonça-Belmont, Andreia Soares Silva, Kleyton Palmeira do Ó, Felipe Borba Ferreira, Fernanda Silva Medeiros, Luydson Richardson Silva Vasconcelos, Moacyr Jesus Barreto de Melo Rego, Marcos Andre Cavalcanti Bezerra, Aderson Silva Araujo, Patricia Muniz Mendes Freire Moura, Ana Claudia Mendonça Anjos, Betânia Lucena Domingues Hatzlhofer, Maria do Socorro Mendonça Cavalcanti

  e2018012

  2018-02-21

  https://doi.org/10.4084/mjhid.2018.012

  2973

  PDF: 939

  HTML: 395

• PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

  Michele Bibas

  e2024007

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.007

  3551

  PDF: 2411

  HTML: 1463

• CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

  Michele Bibas, Jorge J Castillo

  e2014064

  2014-10-22

  https://doi.org/10.4084/mjhid.2014.064

  2605

  PDF: 1605

  HTML: 2354

  Table1: 190

• Should every patient with MDS get iron chelation – probably yes.

  Kanjaksha Ghosh, Emanuele Angelucci, Federica Pilo, Kinjalka Ghosh

  e2017055

  2017-09-01

  https://doi.org/10.4084/mjhid.2017.055

  2312

  PDF: 946

  HTML: 377

• MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA

  Alessandro Granito, Luigi Bolondi

  e2009021

  https://doi.org/10.4084/mjhid.2009.021

  723

  PDF: 465

  HTML: 6265

• DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

  Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso

  e2022030

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.030

  1376

  HTML: 395

  PDF: 820

• TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Marta Muzio, Eleonora Fonte, Federico Caligaris-Cappio

  e2012055

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.055

  2579

  PDF: 862

  HTML: 17469

  Fig1 Caligaris: 172

  Fig.2 Caliga: 203

• INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?

  Francesco Zallio, Giulia Limberti, Marco Ladetto

  e2017035

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.035

  3228

  PDF: 1009

  HTML: 2024

• THE IMPORTANCE OF EPIGENETIC ALTERATIONS IN THE DEVELOPMENT OF EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

  Maria Takacs, Judit Segesdi, Ferenc Banati, Anita Koroknai, Hans Wolf, Hans Helmut Niller, Janos Minarovits

  e2009012

  https://doi.org/10.4084/mjhid.2009.012

  1037

  PDF: 516

  HTML: 2866

• USP9X INCREASED TUMOR ANGIOGENESIS IN MANTLE CELL LYMPHOMA BY UPREGULATION OF CCND1- MEDIATED SOX11

  Gang Huang, Jianjun Liao, Mingli Wang, Yali Huang, Mingjie Tang, Yanyan Hao

  e2022048

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.048

  834

  PDF: 692

  HTML: 207

• PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

  Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag

  e2011055

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.055

  1872

  PDF: 759

  HTML: 1518

• THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

  Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini

  e2016025

  2016-05-01

  https://doi.org/10.4084/mjhid.2016.025

  6312

  PDF: 2112

  HTML: 14015

  Untitled: 199

  figure: 184

• ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

  Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca

  e2020075

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.075

  1515

  PDF: 1406

  HTML: 493

• MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

  Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade

  e2011045

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.045

  2839

  PDF: 848

  HTML: 6519

  Untitled: 226

  Untitled: 189

  Untitled: 205

  Untitled: 210

• PROGNOSTIC VALUE OF BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE MYELOID LEUKEMIA

  adel abd elhaleim hagag

  e2015033

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.033

  2099

  PDF: 827

  HTML: 1140

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  4104

  PDF: 1587

  HTML: 952